Literature DB >> 17964094

Nanostructures from alkyl vitamin C derivatives (ASCn): properties and potential platform for drug delivery.

Santiago Palma1, Ruben Manzo, Pierandrea Lo Nostro, Daniel Allemandi.   

Abstract

Alkyl vitamin C derivatives (ASC(n)) combine in their structure a lipophilic and a hydrophilic moiety and exhibit properties of typical surfactant molecules. Self-assembly properties of ASC(n) depend on the length of n-alkyl fatty chain. ASC(n) start to aggregate at temperatures (CMT, Krafft point) in which the solubility reaches the critical micellar concentration (CMC). Above this temperature, ASC(n) can aggregate in micelles or gel phase, depending of alkyl side chain. Upon cooling, for less soluble derivatives (ASC(12), ASC(14) and ASC(16)) liquid-crystal structures named coagels are obtained. They are able to solubilized insoluble and unstable drugs, protect them from any possible aggressive environment and promote their permeation through skin. Besides, the rheological properties of the coagels would be adequate for topical administration of pharmaceutical. These systems possess very interesting properties making ASC(n) coagels promising pharmaceutical platforms for drug delivery. Results from investigations about all these properties are described and analyzed. Also, the perspectives of these systems as drug delivery systems are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964094     DOI: 10.1016/j.ijpharm.2007.09.014

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Crystalline fibrillar gel formation in aqueous surfactant-antioxidant system.

Authors:  Linet Rose Joseph; B V R Tata; Lisa Sreejith
Journal:  Eur Phys J E Soft Matter       Date:  2015-08-10       Impact factor: 1.890

2.  Drug nanoparticle formulation using ascorbic Acid derivatives.

Authors:  Kunikazu Moribe; Waree Limwikrant; Kenjirou Higashi; Keiji Yamamoto
Journal:  J Drug Deliv       Date:  2011-04-26

3.  Antioxidant-containing monoolein aqueous dispersions: a preliminary study.

Authors:  Maddalena Sguizzato; Markus Drechsler; Anna Baldisserotto; Rita Cortesi; Elisabetta Esposito
Journal:  Drug Deliv Transl Res       Date:  2022-01-27       Impact factor: 5.671

4.  Topical Application of Trisodium Ascorbyl 6-Palmitate 2-Phosphate Actively Supplies Ascorbate to Skin Cells in an Ascorbate Transporter-Independent Manner.

Authors:  Shuichi Shibuya; Ikuyo Sakaguchi; Shintaro Ito; Eiko Kato; Kenji Watanabe; Naotaka Izuo; Takahiko Shimizu
Journal:  Nutrients       Date:  2017-06-22       Impact factor: 5.717

5.  Self-assembled nanostructures of L-ascorbic acid alkyl esters support monomeric amphotericin B.

Authors:  Natalia E Nocelli; Yenisleidy de Las Mercedes Zulueta Díaz; Marine Millot; María Luz Colazo; Raquel V Vico; Maria Laura Fanani
Journal:  Heliyon       Date:  2021-01-28

6.  Multidrug Idebenone/Naproxen Co-loaded Aspasomes for Significant in vivo Anti-inflammatory Activity.

Authors:  Nicola d'Avanzo; Maria Chiara Cristiano; Luisa Di Marzio; Maria Chiara Bruno; Donatella Paolino; Christian Celia; Massimo Fresta
Journal:  ChemMedChem       Date:  2022-03-22       Impact factor: 3.540

7.  Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4+ T Cell-Independent CD8+ T-Cell Response Against Unconjugated Protein Antigen.

Authors:  Ana L Chiodetti; María F Sánchez Vallecillo; Joseph S Dolina; María I Crespo; Constanza Marin; Stephen P Schoenberger; Daniel A Allemandi; Santiago D Palma; María C Pistoresi-Palencia; Gabriel Morón; Belkys A Maletto
Journal:  Front Immunol       Date:  2018-10-10       Impact factor: 8.786

8.  A Vaccine Based on Kunitz-Type Molecule Confers Protection Against Fasciola hepatica Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production.

Authors:  Leonardo Silvane; Daiana Pamela Celias; Pablo Alberto Romagnoli; Belkys Angélica Maletto; María Fernanda Sanchez Vallecillo; Laura Silvina Chiapello; Santiago Daniel Palma; Daniel Alberto Allemandi; Rodrigo Eduardo Fabrizio Sanabria; César Iván Pruzzo; Claudia Cristina Motrán; Laura Cervi
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.